Cargando…
Identification of Cardiac Glycosides as Novel Inhibitors of eIF4A1-Mediated Translation in Triple-Negative Breast Cancer Cells
The eukaryotic translation initiation factor 4F complex (eIF4F) is a potential chemotherapeutic target in triple-negative breast cancer (TNBC). This complex regulates cap-dependent translational initiation and consists of three core proteins: eIF4E, eIF4G, and eIF4A1. In this study, we focus on repo...
Autores principales: | Howard, Cory M., Estrada, Matthew, Terrero, David, Tiwari, Amit K., Raman, Dayanidhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465665/ https://www.ncbi.nlm.nih.gov/pubmed/32759815 http://dx.doi.org/10.3390/cancers12082169 |
Ejemplares similares
-
Role of eIF4A1 in triple‐negative breast cancer stem‐like cell‐mediated drug resistance
por: Raman, Dayanidhi, et al.
Publicado: (2020) -
The CXCR4-LASP1-eIF4F Axis Promotes Translation of Oncogenic Proteins in Triple-Negative Breast Cancer Cells
por: Howard, Cory M., et al.
Publicado: (2019) -
Ethnic disparities in the immune microenvironment of triple negative breast cancer and its role in therapeutic outcomes
por: Zajac, Kelsee K., et al.
Publicado: (2023) -
Tackling of Immunorefractory Tumors by Targeting Alternative Immune Checkpoints
por: Dulal, Dharmindra, et al.
Publicado: (2023) -
The CXCR4-Dependent LASP1-Ago2 Interaction in Triple-Negative Breast Cancer
por: Tilley, Augustus M. C., et al.
Publicado: (2020)